Burning Rock Biotech Cash Flow Statement Analysis

Operating, investing, and financing activities in billions CNY

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Burning Rock Biotech Limited (BNR) - Annual data in billions CNY
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-0.35-0.65-0.14-0.13-0.41
Depreciation & Amortization0.050.130.120.010.03
Stock Based Compensation0.160.260.330.280.17
Change in Working Capital-0.04-0.05-0.010.000.11
Change in Accounts Receivable-0.03-0.02-0.04-0.05-0.04
Change in Inventory0.000.06-0.02-0.07-0.01
Change in Accounts Payable0.02-0.030.02-0.010.03
Change in Other Working Capital-0.03-0.050.040.040.11
Other Operating Activities0.080.040.040.040.00
Net Cash from Operating Activities-0.09-0.26-0.46-0.48-0.07
Investing Activities
Capital Expenditures-0.01-0.01-0.070.03-0.08
Purchases of Investments0.000.000.07-0.06-0.03
Sales/Maturities of Investments0.000.000.070.050.00
Other Investing Activities0.000.000.000.000.00
Net Cash from Investing Activities0.00-0.01-0.010.08-0.11
Financing Activities
Debt Repayment0.000.000.00-0.01-0.04
Common Stock Issued0.00-0.010.000.001.92
Common Stock Repurchased0.00-0.01-0.070.000.00
Other Financing Activities0.00-0.04-0.010.000.00
Net Cash from Financing Activities0.00-0.05-0.09-0.052.17
Summary
Effect of Forex Changes on Cash0.000.000.04-0.01-0.16
Net Change in Cash-0.09-0.31-0.55-0.491.83
Cash at Beginning of Period0.620.931.441.930.10
Cash at End of Period0.520.620.930.231.93
Free Cash Flow-0.10-0.26-0.53-0.48-0.15
Supplemental Disclosures
Interest Paid0.000.000.000.000.00
Income Taxes Paid0.000.000.000.000.00